Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Ciclesonide
Drug ID BADD_D00460
Description Ciclesonide is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.
Indications and Usage For the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.
Marketing Status approved; investigational
ATC Code R01AD13; R03BA08
DrugBank ID DB01410
KEGG ID D01703
MeSH ID C120481
PubChem ID 6918155
TTD Drug ID D0K7HU
NDC Product Code 70515-711; 53104-7633; 70515-712; 70515-701; 64918-1900; 24002-0016; 64918-1112; 70515-737
UNII S59502J185
Synonyms ciclesonide | (R)-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate | Alvesco | Omnaris
Chemical Information
Molecular Formula C32H44O7
CAS Registry Number 126544-47-6
SMILES CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.0020.000834%
Aggression19.05.01.001--Not Available
Alanine aminotransferase increased13.03.04.005--
Amnesia19.20.01.001; 17.03.02.0010.000834%
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.009--Not Available
Anosmia22.04.03.006; 17.04.04.0010.000379%
Anxiety19.06.02.0020.001023%
Aphonia22.12.03.001; 19.19.01.002; 17.02.08.009--
Arthralgia15.01.02.001--
Asphyxia22.02.02.001; 12.01.08.0110.000379%Not Available
Asthenia08.01.01.001--Not Available
Asthma22.03.01.002; 10.01.03.0100.005533%Not Available
Atrial fibrillation02.03.03.0020.000834%
Back pain15.03.04.005--
Bronchitis22.07.01.001; 11.01.09.001--
Bronchospasm22.03.01.004; 10.01.03.0120.000379%
Bronchospasm paradoxical22.03.01.006--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cardiac failure02.05.01.0010.000379%
Cataract06.06.01.001--
Cataract subcapsular06.06.01.002--Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.0090.001402%Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.001--
Choking22.12.03.0030.000379%Not Available
Chronic obstructive pulmonary disease22.03.01.0070.001516%Not Available
Condition aggravated08.01.03.0040.000568%Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Cough22.02.03.0010.002160%
Crohn's disease10.02.01.005; 07.08.01.015--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 6 Pages